While the U.S. remains the only other country besides New Zealand to allow direct advertising of pharmaceuticals to consumers, the new crackdown risks further upsetting a multi-billion-dollar industry that Trump has repeatedly targeted as Americans have increasingly grown sick of high drug costs.